NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
- EBITDA, 2025
- −$80M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$80M | — |
| 2024 | −$53M | — |
| 2023 | −$70M | — |
| 2022 | −$122M | — |
| 2021 | −$89M | — |
| 2020 | $12M | −64.3% |
| 2019 | $33M | +29.1% |
| 2018 | $26M | +39.7% |
| 2017 | $18M | +2.2% |
| 2016 | $18M | +1,552.2% |
| 2015 | $1.1M | −85.5% |
| 2014 | $7.6M | +2.7% |
| 2013 | $7.4M | +51.9% |
| 2012 | $4.8M | +189.2% |
| 2011 | $1.7M | — |
| 2010 | −$1.2M | — |